Unknown PHASE2 INTERVENTIONAL 2-arm NCT00906386

Methadone Maintenance Treatment and Smoking Cessation (MMTASC)

An Examination of the Efficacy, Safety, and Gender Differences in Using Varenicline as an Aid to Smoking Cessation in a Population of Methadone Maintained Opioid Dependent Patients (Pilot Trial)

Sponsor: British Columbia Centre of Excellence for Women's Health

Conditions Smoking

Interventions Varenicline placebo

Updated 6 times since 2017 Last updated: Mar 1, 2010 Started: May 31, 2009 Primary completion: Oct 31, 2009 Completion: Feb 28, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00906386, this PHASE2 trial focuses on Smoking and remains ongoing. Sponsored by British Columbia Centre of Excellence for Women's Health, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation PHASE2

First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

British Columbia Centre of Excellence for Women's Health
Vancouver Coastal Health

Data source: Vancouver Coastal Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vancouver, Canada